InMed Pharmaceuticals Inc.
For the period ended Sep 30, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 3, 2026
INM$15.56+17.8%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited Condensed Consolidated Financial Statements of
For the Three Months Ended September 30, 2026 and 2025
(Expressed in U.S. Dollars)
September 30, 2026
| INDEX | Page | |
|---|---|---|
| Financial Statements | ||
| ● | Condensed Consolidated Balance Sheets as of September 30, 2026 (unaudited) and June 30, 2026 | 3 |
| ● | Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2026 and 2025 (unaudited) | 4 |
| ● | Condensed Consolidated Statements of Shareholders’ Equity for the Three Months Ended September 30, 2026 and 2025 (unaudited) | 5 |
| ● | Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2026 and 2025 (unaudited) | 6 |
| ● | Notes to the Condensed Consolidated Financial Statements | 7-18 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.